Low Levels of Serum Ghrelin and Nesfatin-1 Are Associated With Anxiety Disorders in Children

dc.contributor.author Bilgiç, A.
dc.contributor.author Cura, M.
dc.contributor.author Kılınç, İ.
dc.contributor.author Akça, Ö.F.
dc.date.accessioned 2025-04-25T19:49:55Z
dc.date.available 2025-04-25T19:49:55Z
dc.date.issued 2025
dc.description.abstract Objectives: Because appetite-regulating hormones are implicated in neuronal survival, growth, and differentiation, they have been suggested to play a role in anxiety disorders. To date, few studies have focused on the association between these hormones and anxiety disorders in children. This study investigated the potential differences in leptin, ghrelin, and nesfatin-1 serum levels in drug-naïve children with anxiety disorders, including social anxiety disorder, separation anxiety disorder, and generalized anxiety disorder, and in healthy controls. Methods: This study included 45 children (14 boys and 31 girls) with anxiety disorders and 35 healthy controls (13 boys and 22 girls) aged 8–18 years. The severity of anxiety disorders and additional symptoms were evaluated using the Revised Child Anxiety and Depression Scales–Child Version. Enzyme-linked immunosorbent assay (ELISA) was used to evaluate leptin, ghrelin, and nesfatin-1 serum levels. Results: Leptin levels were significantly higher in children with anxiety disorders than in the control group, and ghrelin and nesfatin-1 levels were significantly lower in children with anxiety disorders than in the control group for girls and for the entire sample. However, only low nesfatin-1 levels were significantly associated with anxiety disorders in boys. In the entire sample, potential confounders such as age, sex, body mass index, and the severity of depressive symptoms were controlled for, and the results were the same for ghrelin and nesfatin-1 levels. However, the difference in leptin levels between groups was not significant. Conclusion: These findings suggest that dysregulation of ghrelin and nesfatin-1 concentrations may be related to the etiopathogenesis of childhood anxiety disorders. © 2025 Korean Academy of Child and Adolescent Psychiatry. en_US
dc.identifier.doi 10.5765/jkacap.250001
dc.identifier.issn 1225-729X
dc.identifier.issn 2233-9183
dc.identifier.scopus 2-s2.0-105002603201
dc.identifier.uri https://doi.org/10.5765/jkacap.250001
dc.identifier.uri https://hdl.handle.net/20.500.14365/6067
dc.language.iso en en_US
dc.publisher Korean Academy of Child and Adolescent Psychiatry en_US
dc.relation.ispartof Journal of the Korean Academy of Child and Adolescent Psychiatry en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Anxiety Disorder en_US
dc.subject Children en_US
dc.subject Ghrelin en_US
dc.subject Leptin en_US
dc.subject Nesfatin-1 en_US
dc.title Low Levels of Serum Ghrelin and Nesfatin-1 Are Associated With Anxiety Disorders in Children en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 14628451300
gdc.author.scopusid 59252599100
gdc.author.scopusid 6603272650
gdc.author.scopusid 35321134900
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Ekonomi Üniversitesi en_US
gdc.description.departmenttemp [Bilgiç A.] Department of Child and Adolescent Psychiatry, Faculty of Medicine, Izmir University of Economics, Izmir, Turkey; [Cura M.] Department of Child and Adolescent Psychiatry, Etlik City Hospital, Ankara, Turkey; [Kılınç İ.] Department of Biochemistry, Necmettin Erbakan University Faculty of Medicine, Konya, Turkey; [Akça Ö.F.] Department of Child and Adolescent Psychiatry, Necmettin Erbakan University, Faculty of Medicine, Konya, Turkey en_US
gdc.description.endpage 77 en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 69 en_US
gdc.description.volume 36 en_US
gdc.description.woscitationindex Emerging Sources Citation Index
gdc.description.wosquality Q3
gdc.identifier.openalex W4409176211
gdc.identifier.pmid 40203141
gdc.identifier.wos WOS:001460829700004
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.accesstype GOLD
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.4895952E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Original Article
gdc.oaire.popularity 2.7494755E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration National
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.07
gdc.opencitations.count 0
gdc.plumx.mendeley 2
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
gdc.wos.citedcount 0
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery e9e77e3e-bc94-40a7-9b24-b807b2cd0319

Files